Picture of Open Access badges

Discover Open Access research at Strathprints

It's International Open Access Week, 24-30 October 2016. This year's theme is "Open in Action" and is all about taking meaningful steps towards opening up research and scholarship. The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs. Explore recent world leading Open Access research content by University of Strathclyde researchers and see how Strathclyde researchers are committing to putting "Open in Action".


Image: h_pampel, CC-BY

Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721

Crockett, Thomas R. and Scott, Gillian A. and McGowan, Neil W.A. and Kane, Kathleen A. and Wainwright, Cherry L. (2001) Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721. European Journal of Pharmacology, 432 (1). pp. 71-77. ISSN 0014-2999

Full text not available in this repository. (Request a copy from the Strathclyde author)


The effects of the endothelin ETA, (BQ-123) and endothelin ETA/B (PD161721) receptor antagonists were investigated on ischaemia-induced arrhythmias and on the maximum following frequency. The study was carried out in Langendorff perfused rat hearts subjected to coronary artery occlusion in which the severity of arrhythmias, coronary perfusion pressure and heart rate were measured. The % incidence of ischaemia-induced irreversible ventricular fibrillation (ventricular fibrillation) was reduced significantly from 58%, in control rat hearts, to 0% (at 10(-7) and 10(-6) M PD161721 and 10(-6) M BQ-123 P < 0.05). Maximum following frequency was measured in guinea-pig isolated atria. In the presence of normal extracellular [K+], BQ-123 and PD161721, at 10(-6) M, significantly decreased the maximum following frequency from 9.0 +/- 0.7 to 7.2 +/- 0.4 and from 8.3 +/- 0.4 to 6.7 +/- 0.3 Hz, respectively (P < 0.05). These effects were not potentiated by raising the extracellular [K+] with the exception of 10(-9) M PD161721. In contrast, lignocaine's ability to reduce the maximum following frequency was greater in elevated (e.g. at 1.7 X 10(-4) M from 8.4 +/- 0.3 to 2.5 +/- 0.6 Hz) than in normal [K+] (from 9.0 +/- 0.3 to 4.9 +/- 0.5 Hz). In conclusion, both BQ-123 and PD161721 had an anti-fibrillatory effect in isolated rat hearts that may be due, at least in part, to an ability to reduce the maximum following frequency. This latter effect is unlikely to be due to Na+ channel blockade since it was not markedly potentiated by elevation of extracellular [K+].